These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28193090)

  • 1. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.
    Shah NS; Duong YT; Le LV; Tuan NA; Parekh BS; Ha HTT; Pham QD; Cuc CTT; Dobbs T; Tram TH; Lien TTX; Wagar N; Yang C; Martin A; Wolfe M; Hien NT; Kim AA
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):546-554. PubMed ID: 28193090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
    Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
    PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
    Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
    PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda.
    Longosz AF; Serwadda D; Nalugoda F; Kigozi G; Franco V; Gray RH; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):339-44. PubMed ID: 24083837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field Validation of Limiting-Antigen Avidity Enzyme Immunoassay to Estimate HIV-1 Incidence in Cross-Sectional Survey in Swaziland.
    Duong YT; Dobbs T; Mavengere Y; Manjengwa J; Rottinghaus E; Saito S; Bock N; Philip N; Justman J; Bicego G; Nkengasong JN; Parekh BS
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):896-905. PubMed ID: 31204867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a New Limiting-Antigen Avidity Dot Immuno-Gold Filtration Assay for HIV-1 Incidence.
    Gao Z; Yan H; Feng X; Wu L; Qiu M; Xing W; Zhang G; Zhang Z; Jiang Y
    PLoS One; 2016; 11(8):e0161183. PubMed ID: 27513563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.
    Duong YT; Kassanjee R; Welte A; Morgan M; De A; Dobbs T; Rottinghaus E; Nkengasong J; Curlin ME; Kittinunvorakoon C; Raengsakulrach B; Martin M; Choopanya K; Vanichseni S; Jiang Y; Qiu M; Yu H; Hao Y; Shah N; Le LV; Kim AA; Nguyen TA; Ampofo W; Parekh BS
    PLoS One; 2015; 10(2):e0114947. PubMed ID: 25710171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
    Kim AA; Rehle T
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.
    Konikoff J; Brookmeyer R; Longosz AF; Cousins MM; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Koblin BA; Justman JE; Hodder SL; Quinn TC; Eshleman SH; Laeyendecker O
    PLoS One; 2013; 8(12):e82772. PubMed ID: 24386116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.
    Laeyendecker O; Gray RH; Grabowski MK; Reynolds SJ; Ndyanabo A; Ssekasanvu J; Fernandez RE; Wawer MJ; Serwadda D; Quinn TC
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):364-367. PubMed ID: 30560723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a novel rapid test for recent HIV infection among newly-diagnosed pregnant adolescent girls and young women in four high-HIV-prevalence districts-Malawi, 2017-2018.
    Agyemang EA; Kim AA; Dobbs T; Zungu I; Payne D; Maher AD; Curran K; Kim E; Kwalira H; Limula H; Adhikari A; Welty S; Kandulu J; Nyirenda R; Auld AF; Rutherford GW; Parekh BS
    PLoS One; 2022; 17(2):e0262071. PubMed ID: 35148312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating HIV incidence in the Akwa Ibom AIDS indicator survey (AKAIS), Nigeria using the limiting antigen avidity recency assay.
    Negedu-Momoh OR; Balogun O; Dafa I; Etuk A; Oladele EA; Adedokun O; James E; Pandey SR; Khamofu H; Badru T; Robinson J; Mastro TD; Torpey K
    J Int AIDS Soc; 2021 Feb; 24(2):e25669. PubMed ID: 33619853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the limiting antigen avidity EIA (LAg) in people who inject drugs in Greece.
    Nikolopoulos GK; Katsoulidou A; Kantzanou M; Rokka C; Tsiara C; Sypsa V; Paraskevis D; Psichogiou M; Friedman S; Hatzakis A
    Epidemiol Infect; 2017 Jan; 145(2):401-412. PubMed ID: 27780490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of prospective and cross-sectional measures of HIV type 1 incidence in a higher-risk cohort in Ho Chi Minh City, Vietnam.
    Sexton CJ; Costenbader EC; Vinh DT; Chen PL; Hoang TV; Lan NT; Feldblum P; Kim A; Giang le T
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):866-73. PubMed ID: 21936716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short Communication: Comparison of Maxim and Sedia Limiting Antigen Assay Performance for Measuring HIV Incidence.
    Schlusser KE; Konikoff J; Kirkpatrick AR; Morrison C; Chipato T; Chen PL; Munjoma M; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2017 Jun; 33(6):555-557. PubMed ID: 28318310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sectional estimates revealed high HIV incidence in Botswana rural communities in the era of successful ART scale-up in 2013-2015.
    Moyo S; Gaseitsiwe S; Mohammed T; Pretorius Holme M; Wang R; Kotokwe KP; Boleo C; Mupfumi L; Yankinda EK; Chakalisa U; van Widenfelt E; Gaolathe T; Mmalane MO; Dryden-Peterson S; Mine M; Lebelonyane R; Bennett K; Leidner J; Wirth KE; Tchetgen Tchetgen E; Powis K; Moore J; Clarke WA; Lockman S; Makhema JM; Essex M; Novitsky V
    PLoS One; 2018; 13(10):e0204840. PubMed ID: 30356287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection.
    Verhofstede C; Fransen K; Van Den Heuvel A; Van Laethem K; Ruelle J; Vancutsem E; Stoffels K; Van den Wijngaert S; Delforge ML; Vaira D; Hebberecht L; Schauvliege M; Mortier V; Dauwe K; Callens S
    BMC Infect Dis; 2017 Nov; 17(1):738. PubMed ID: 29187159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana.
    Moyo S; Kotokwe KP; Mohammed T; Boleo C; Mupfumi L; Chishala S; Tsalaile L; Bussmann H; Gaseitsiwe S; Musonda R; Makhema J; Baum M; Marlink R; Engelbrecht S; Essex M; Novitsky V
    AIDS Res Hum Retroviruses; 2017 Jan; 33(1):17-18. PubMed ID: 27481530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison among the BED capture enzyme immunoassay test and AxSYM avidity index assay for determining recent HIV infection and incidence in two Voluntary Counselling and Testing Centres in Northeast Brazil.
    Salustiano DM; Lima KO; Cavalcanti AM; Diaz RS; Lacerda HR
    Braz J Infect Dis; 2014; 18(4):449-53. PubMed ID: 24780363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.